Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V. (ATAI) is a Great Choice
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at atai Life Sciences N.V. (ATAI), which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Atai Life Sciences N.V. Currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Let's discuss some of the components of the Momentum Style Score for ATAI that show why this company shows promise as a solid momentum pick.
A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area.
For ATAI, shares are up 4.33% over the past week while the Zacks Medical - Outpatient and Home Healthcare industry is up 2.9% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 73.38% compares favorably with the industry's 3.66% performance as well.
While any stock can see its price increase, it takes a real winner to consistently beat the market. That is why looking at longer term price metrics -- such as performance over the past three months or year -- can be useful as well. Shares of atai Life Sciences N.V. Have increased 62.84% over the past quarter, and have gained 73.38% in the last year. In comparison, the S&P 500 has only moved 4.9% and 13.46%, respectively.
Investors should also pay attention to ATAI's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. ATAI is currently averaging 2,843,733 shares for the last 20 days.
The Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with ATAI.
Over the past two months, 3 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost ATAI's consensus estimate, increasing from -$0.75 to -$0.60 in the past 60 days. Looking at the next fiscal year, 2 estimates have moved upwards while there have been 1 downward revision in the same time period.
Given these factors, it shouldn't be surprising that ATAI is a #2 (Buy) stock and boasts a Momentum Score of A. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep atai Life Sciences N.V. On your short list.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
atai Life Sciences N.V. (ATAI) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
UNFI's Q3 Earnings Coming Up: What Investors Need to Understand
United Natural Foods, Inc. UNFI is likely to register growth in its top and bottom lines when it reports third-quarter fiscal 2025 earnings on June 10. The Zacks Consensus Estimate for revenues is pegged at $7.85 billion, implying a 4.6% increase from the prior-year quarter's reported figure. The consensus mark for earnings has moved up by a penny in the past 30 days to 24 cents per share, indicating a substantial increase from 10 cents reported in the year-ago quarter. UNFI has a trailing four-quarter earnings surprise of 408.7%, on average. (Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.) United Natural continues to showcase growth and operational resilience, fueled by strong demand within its wholesale segment and growing consumer preference for natural and organic products. The company is capitalizing on these favorable trends through targeted strategic initiatives — including customer base expansion, distribution network optimization and increased investment in automation — which are boosting both efficiency and market company's lean management practices have been instrumental in enhancing operational effectiveness by aligning supply with evolving customer needs and delivering meaningful cost savings. Notably, the natural products category remains the key growth driver across UNFI's portfolio, a trend expected to persist in the coming addition, disciplined SG&A management, ongoing supply-chain optimization and productivity improvements are further supporting United Natural's performance. The continuation of such trends is expected to have positively impacted the company's fiscal third-quarter performance. United Natural Foods, Inc. price-eps-surprise | United Natural Foods, Inc. Quote Our proven model doesn't conclusively predict an earnings beat for United Natural this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Natural currently has a Zacks Rank #3 and an Earnings ESP of 0.00%. Here are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings this reporting Hershey Company HSY currently has an Earnings ESP of +0.83% and a Zacks Rank of 3. You can see the complete list of today's Zacks #1 Rank stocks company is likely to register top-line growth when it reports second-quarter fiscal 2025 results. The consensus mark for Hershey's quarterly revenues is pegged at $2.5 billion, which indicates an increase of 20% from the figure reported in the prior-year Zacks Consensus Estimate for Hershey's quarterly earnings per share (EPS) is pegged at 99 cents, indicating a 22.1% decline from the year-ago period. HSY delivered a trailing four-quarter earnings surprise of 0.6%, on International, Inc. MDLZ currently has an Earnings ESP of +0.62% and a Zacks Rank #3. The company is likely to register top-line growth when it reports second-quarter 2025 results. The Zacks Consensus Estimate for Mondelez's quarterly revenues is pegged at $8.9 billion, which indicates an increase of 6.1% from the figure reported in the prior-year Zacks Consensus Estimate for Mondelez's quarterly EPS is pegged at 68 cents, indicating a 20.9% decline from the year-ago period. MDLZ delivered a trailing four-quarter earnings surprise of 9.8%, on J. M. Smucker Company SJM currently has an Earnings ESP of +7.42% and a Zacks Rank of 3. The consensus estimate for J. M. Smucker's fourth-quarter fiscal 2025 revenues is pegged at $2.2 billion, which indicates a drop of 0.8% from the figure reported in the prior-year quarter. SJM delivered a trailing four-quarter earnings surprise of 11.7%, on Zacks Consensus Estimate for Smucker's fiscal fourth-quarter EPS is pegged at $2.25, which implies a 15.4% decrease year over year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hershey Company (The) (HSY) : Free Stock Analysis Report The J. M. Smucker Company (SJM) : Free Stock Analysis Report United Natural Foods, Inc. (UNFI) : Free Stock Analysis Report Mondelez International, Inc. (MDLZ) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
International Equity ETF (VT) Hits New 52-Week High
For investors seeking momentum, Vanguard Total World Stock ETF VT is probably on the radar. The fund just hit a 52-week high and is up 24.54% from its 52-week low price of $100.89/share. But are more gains in store for this ETF? Let's take a quick look at the fund and the near-term outlook on it to get a better idea of where it might be headed: The underlying FTSE Global All Cap Index is a float-adjusted, market-capitalization-weighted index designed to measure the market performance of large, mid and small-capitalization stocks of companies located around the world. The fund has major allocations to the United States (61.87%), Japan (5.98%) and the U.K. (3.59%). The product charges 6 bps in annual fees (See: All World Small/Mid Stock ETF). The international equity corner of the market has been an area to watch lately, driven by easing trade tensions. Additionally, robust Q1 earnings across major economies and renewed investor enthusiasm for AI also boost the fund's prospects. Washington and Beijing resuming trade talks in London, is a key tailwind. Currently, VT has a Zacks ETF Rank #3 (Hold) with a Low risk outlook. However, it might continue its strong performance in the near term, with a positive weighted alpha of 12.69 (as of which gives cues of a further rally. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Vanguard Total World Stock ETF (VT): ETF Research Reports This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Canadian Imperial Bank (CM) Is Up 1.31% in One Week: What You Should Know
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us. Below, we take a look at Canadian Imperial Bank (CM), which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions. It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Canadian Imperial Bank currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period. You can see the current list of Zacks #1 Rank Stocks here >>> In order to see if CM is a promising momentum pick, let's examine some Momentum Style elements to see if this bank and financial services company holds up. Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area. For CM, shares are up 1.31% over the past week while the Zacks Banks - Foreign industry is up 0.88% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 8.43% compares favorably with the industry's 5.83% performance as well. While any stock can see a spike in price, it takes a real winner to consistently outperform the market. Over the past quarter, shares of Canadian Imperial Bank have risen 22.54%, and are up 40.5% in the last year. On the other hand, the S&P 500 has only moved 4.9% and 13.46%, respectively. Investors should also pay attention to CM's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. CM is currently averaging 1,040,096 shares for the last 20 days. The Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with CM. Over the past two months, 6 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost CM's consensus estimate, increasing from $5.58 to $5.88 in the past 60 days. Looking at the next fiscal year, 5 estimates have moved upwards while there have been no downward revisions in the same time period. Taking into account all of these elements, it should come as no surprise that CM is a #2 (Buy) stock with a Momentum Score of A. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Canadian Imperial Bank on your short list. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Canadian Imperial Bank of Commerce (CM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
